1)Perugino CA, Stone JH:IgG4-related disease;An update on pathophysiology and implications for clinical care. Nat Rev Rheumatol 16:702-714, 2020
2)Hao M, et al:Diagnostic value of serum IgG4 for IgG4-related disease;A PRISMA-compliant systematic review and meta-analysis. Medicine(Baltimore)95:e3785, 2016
3)Qi R, et al:Utility of serum IgG4 levels in a multiethnic population. Am J Med Sci 355:61-66, 2018
4)Lanzillotta M, et al:Advances in the diagnosis and management of IgG4 related disease. BMJ 369:m1067, 2020
5)日本IgG4関連疾患学会:2020年改訂IgG4関連疾患包括診断基準 https://igg4.w3.kanazawa-u.ac.jp/reference/(2022年3月閲覧)
6)Wallace ZS, et al:The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol 72:7-19, 2020
7)Yamamoto M, et al:Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol 22:419-425, 2012
8)Nishikori A, et al:Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease. Pathol Int 72:43-52, 2022
9)Della TE, et al:Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 69:269-272, 2014